Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
07 2021
Historique:
received: 03 11 2020
revised: 12 04 2021
accepted: 29 04 2021
pubmed: 15 6 2021
medline: 21 10 2021
entrez: 14 6 2021
Statut: ppublish

Résumé

Impairments in social functioning are a core impairment in psychosis and are associated with poor outcomes. These deficits are found in those at clinical high-risk (CHR) for psychosis, and can persist even in the absence of transition. However, the neurobiological underpinnings of social functioning remain unclear, therefore we conducted a systematic review of brain metrics that have been associated with social functioning in youth at CHR for psychosis. Five databases (MEDLINE, CINAHL, EBM reviews, Embase, and PsycINFO) were searched from inception to May 5, 2020. Studies were selected if they examined brain imaging, and social functioning in youth at CHR for psychosis. Of the 9629 citations found through online database searching, 12 studies with 696 CHR participants met inclusion criteria. Too few studies were focused on the same brain region using the same methodology to perform a meta-analysis, however, loci within the prefrontal cortex were most often associated with social functioning. Few studies have linked social functioning to brain imaging metrics, suggesting that future work should focus on this relationship.

Identifiants

pubmed: 34126554
pii: S0920-9964(21)00159-6
doi: 10.1016/j.schres.2021.04.013
pmc: PMC8380704
mid: NIHMS1714097
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-12

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH105178
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081984
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Am J Psychiatry. 2011 Aug;168(8):806-13
pubmed: 21536691
Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91
pubmed: 23769814
Neurosci Biobehav Rev. 2016 Dec;71:680-690
pubmed: 27773693
PLoS One. 2015 Aug 07;10(8):e0134936
pubmed: 26252525
Schizophr Res. 2010 Feb;116(2-3):173-83
pubmed: 19861234
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
Schizophr Res. 2020 Aug;222:104-112
pubmed: 32522469
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
Schizophr Bull. 2007 May;33(3):688-702
pubmed: 17440198
Schizophr Bull. 2017 Jan;43(1):57-63
pubmed: 27798225
Schizophr Bull. 2012 Nov;38(6):1247-57
pubmed: 22080497
Am J Psychiatry. 2017 Nov 1;174(11):1075-1085
pubmed: 27978770
Biol Psychiatry. 2009 Sep 15;66(6):562-9
pubmed: 19423081
Br J Psychiatry. 2011 Jun;198(6):448-56
pubmed: 21628707
JAMA Psychiatry. 2013 Nov;70(11):1133-42
pubmed: 24006090
J Neurosci. 2017 May 17;37(20):5065-5073
pubmed: 28432144
Schizophr Res. 2020 Dec;226:84-94
pubmed: 30683525
Schizophr Res. 2014 Sep;158(1-3):52-7
pubmed: 25008792
Schizophr Bull. 2017 Mar 1;43(2):449-458
pubmed: 27369472
Schizophr Res. 2017 Nov;189:9-18
pubmed: 28268041
Schizophr Bull. 2020 Feb 26;46(2):236-241
pubmed: 31598707
Schizophr Bull. 2013 Nov;39(6):1296-306
pubmed: 23172003
Acta Psychiatr Scand. 2018 Jan;137(1):65-78
pubmed: 29143980
Am J Psychiatry. 2008 Aug;165(8):1024-32
pubmed: 18558643
Acta Psychiatr Scand. 2007 Dec;116(6):403-18
pubmed: 17941964
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
Psychol Med. 2019 Jul;49(10):1670-1677
pubmed: 30176955
Schizophr Res Cogn. 2015 Sep;2(3):133-139
pubmed: 27695675
Schizophr Res. 2015 Dec;169(1-3):204-208
pubmed: 26530628
Psychol Med. 2017 Nov;47(15):2689-2707
pubmed: 28464976
Clin Psychol Rev. 2018 Jul;63:12-24
pubmed: 29870953
Br J Psychiatry. 2013 Jan;202(1):50-5
pubmed: 23284150
Psychiatry Res. 2019 Feb;272:737-743
pubmed: 30832194
Front Neuroanat. 2018 Sep 19;12:77
pubmed: 30283306
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
Front Psychiatry. 2018 Nov 09;9:574
pubmed: 30473669
Schizophr Res. 2015 May;164(1-3):1-7
pubmed: 25728833
Neuropsychopharmacology. 2016 Apr;41(5):1241-50
pubmed: 26354046
Arch Gen Psychiatry. 1976 Sep;33(9):1111-5
pubmed: 962494
Schizophr Res. 2014 Dec;160(1-3):136-41
pubmed: 25468184
Schizophr Res. 2016 Mar;171(1-3):176-81
pubmed: 26785807
Am J Psychiatry. 2006 Nov;163(11):1926-33
pubmed: 17074944
Psychol Med. 2008 Jun;38(6):877-85
pubmed: 17949516
Schizophr Res. 2019 Jan;203:99-104
pubmed: 29070442
Schizophr Bull. 2015 Jan;41(1):211-22
pubmed: 24583906
Arch Gen Psychiatry. 2009 Aug;66(8):811-22
pubmed: 19652121
Br J Psychiatry. 2006 Oct;189:337-45
pubmed: 17012657
Mol Psychiatry. 2019 May;24(5):633-642
pubmed: 30242229
Schizophr Res. 2014 Apr;154(1-3):93-9
pubmed: 24630136
JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172
pubmed: 30267047
Harv Rev Psychiatry. 2020 Nov/Dec;28(6):341-355
pubmed: 33156155

Auteurs

Paul D Metzak (PD)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: paul.metzak@ucalgary.ca.

Megan S Farris (MS)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: megan.farris@ucalgary.ca.

Thea Placsko (T)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: thea.placsko@ucalgary.ca.

Amy Braun (A)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: amy.braun1@ucalgary.ca.

Dominique Bonneville (D)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: dominique.bonneville@ucalgary.ca.

Kali Brummitt (K)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: kali.brummitt@ucalgary.ca.

Monica Chu (M)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: mochu@ucalgary.ca.

Jean Addington (J)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, 3330 Hospital Dr NW, Calgary T2N 4N1, AB, Canada; Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW, Calgary T2N 4Z6, AB, Canada. Electronic address: jmadding@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH